Find Clinical Trials
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT).
Servier Protocol Code:
CL3-12911-030
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2007-001509-11
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Osteoporosis
- S012911
- STRONTIUM RANELATE
Other study id numbers
Other identification numbers the study may be known by.
- CL3-12911-030